Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye Tracking Sensor for Cannabis Impairment
NCT03994926Phase 1Terminated
- Sponsor
- Battelle
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial in cannabis intoxication, sponsored by Battelle. Primary endpoints: Pupil Dilation at 240 months, Gaze Nystagmus at 240 months and 1 more. Started Feb 2020; status: terminated.
02
Conditions
cannabis intoxication
Beyond the preview
Go deeper on NCT03994926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994926.